For the quarter ended March 31, 2025, Edesa reported a net loss of $1.6 million, or $0.30 per common share, compared to a net ...

Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

The University of California, Davis has announced two new strategic partnerships designed to strengthen its position as a ...

Dr Singh described India as the emerging global biotech destination and said that this is the most appropriate venue for such ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.

As the life sciences field evolves, organizations must ensure career paths in research and development are keeping up.

Thai researchers have made an advancement by developing a rubber serum for medical use, showing potential in combating ...

CHENNAI: Hyderabad emerged as a prominent global centre of life sciences manufacturing activity in India. One of the most ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...